In prostate cancer one of the most frequently mutated/deleted genes is the tumor suppressor gene phosphatase and tensin homolog (Pten), a negative regulator of PI3K activity and thus AKT pathway [10]. This evidence concerns the gene PTEN and prostate carcinoma.